Time-to-Market Risk
Delays in critical study pathways can push back market entry and exclusivity windows—with significant economic implications.
AI-powered processes accelerate key workflows and significantly shorten the recruitment phase. This saves you time, reduces costs, and increases planning certainty throughout the entire trial process.
A central data platform brings together clinical data, omics data, and study information within a unified structure, thereby laying the foundation for reliable analyses. Building on this, AI algorithms automatically match patient profiles against the study’s inclusion and exclusion criteria. The AI identifies suitable participants more quickly and selects them specifically, significantly accelerating recruitment. At the same time, a secure data room enables collaboration with hospitals and research partners without losing control over sensitive data. Analyses can be conducted across multiple locations while responsibilities remain clearly defined. The required computing power is provided flexibly and can be scaled as needed. This keeps costs manageable without requiring you to build your own infrastructure.
The combination of a data platform and a sovereign cloud accelerates study processes and builds trust with your partners. At the same time, it establishes stable frameworks for the use of sensitive data.

Provide scalable computing power for your analytics and AI models.

Store large clinical datasets securely and with high availability.

Reliably process structured study data in a high-performance database.

Seamlessly integrate specialized analytics and research solutions into your platform.